Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
Affiliations: Department of Hematology, Siping Hospital of China Medical University, Siping, Jilin 136000, P.R. China, Jilin Tuhua Bioengineering Company Ltd., Siping, Jilin 136000, P.R. China, Department of Tissue Engineering, China Medical University, Shenyang, Liaoning 110122, P.R. China, Department of Vascular Surgery, Xuanwu Hospital of Capital Medical University, Beijing 100053, P.R. China
- Published online on: March 14, 2017 https://doi.org/10.3892/etm.2017.4229
- Pages: 2255-2258
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.